why choose us

First received: February 08, 2023

Clinical Trial: Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Dry Eye Syndromes

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Active Control, Parallel Group, Randomized, Double-blind, Phase II Clinical Trial to Evaluate the Efficacy and Safety of SCAI-001 Eye Drops in Patients With Dry Eye Disease

Brief Summary: This study is planned to Evaluate the Efficacy and Safety of SCAI-001 Eye Drops(Cyclosporine 0.01%, 0.02%) compared to Restasis(Cyclosporine 0.05%) in Patients with Dry Eye Disease.

Read more